Enzo Spisni

Associate Professor at the University of Bologna, since 2000 he carries out his research in the physiology of the gastro-intestinal tract and human nutrition. The research interests are focused in particular on intestinal inflammation and on the relationships between food, intestinal microbiota and low grade chronic inflammation. Currently he focuses his research on the modulation of intestinal microbiota through food and non-probiotic food supplements.
Engaged in national and international research projects, he collaborates with various companies in the Food and Pharma sectors. Author of over 80 publications, he is CEO of Startup Targeting Gut Disease, a company with shareholding of the University of Bologna. Go to the Curriculum vitae